Evidence map›Paper›PMID 35534729›Full record

ArticleNature metabolism2022

Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth.

Chunming Cheng, Feng Geng, Zoe Li, Yaogang Zhong, Huabao Wang, Xiang Cheng, Yue Zhao, Xiaokui Mo, Craig Horbinski, Wenrui Duan and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nature metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Association ofGenes · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Fermented Milk as an Alternative Therapy for Obesity.International journal of food science · 2026
    Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Chunming ChengDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-9036-1683
Feng GengDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA.
Zoe LiDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy at The Ohio State University, Columbus, OH, USA.
Yaogang ZhongDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA.
Huabao WangDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA.
Xiang ChengDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-5315-9830
Yue ZhaoBioinformatics Shared Resource Group, Department of Biomedical Informatics, College of Medicine at The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-6029-7123
Xiaokui MoBiostatistic Center and Department of Biomedical Informatics, College of Medicine at The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-9797-2687
Craig HorbinskiDepartments of Pathology and Neurosurgery, Feinberg School of Medicine at Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-8340-9992
Wenrui DuanDepartment of Human and Molecular Genetics, Herbert Wertheim College of Medicine at the Florida International University, Miami, FL, USA.
Arnab ChakravartiDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA.
Xiaolin ChengDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy at The Ohio State University, Columbus, OH, USA.
Deliang GuoDepartment of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, and College of Medicine at The Ohio State University, Columbus, OH, USA. deliang.guo@osumc.edu.ORCID http://orcid.org/0000-0002-8359-390X
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USThe Ohio State University · USFlorida International University · USNorthwestern University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Determining the role of lipid droplets in glioblastoma and their therapeutic potentialR01NS104332 · NINDS · OHIO STATE UNIVERSITY · PI Deliang Guo · 2018 to 2026
$4.2M
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanismsR01CA240726 · NCI · OHIO STATE UNIVERSITY · PI GUO, DELIANG · 2020 to 2024
$2.2M
Identifying SREBP-1 activation mechanism in glioblastoma and its new role in regulating glutamine metabolismR01NS112935 · NINDS · OHIO STATE UNIVERSITY · PI GUO, DELIANG · 2020 to 2024
$1.8M
Defining the molecular mechanisms regulating the hexosamine-N-glycosylation pathway in glioblastomaR01CA227874 · NCI · OHIO STATE UNIVERSITY · PI CHAKRAVARTI, ARNAB, GUO, DELIANG · 2019 to 2023
$1.5M
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA227874NCI NIH HHS R01 CA240726NINDS NIH HHS R01 NS104332NINDS NIH HHS R01 NS112935
6 · The paper itself

Abstract

Tumorigenesis is associated with elevated glucose and glutamine consumption, but how cancer cells can sense their levels to activate lipid synthesis is unknown. Here, we reveal that ammonia, released from glutamine, promotes lipogenesis via activation of sterol regulatory element-binding proteins (SREBPs), endoplasmic reticulum-bound transcription factors that play a central role in lipid metabolism. Ammonia activates the dissociation of glucose-regulated, N-glycosylated SREBP-cleavage-activating protein (SCAP) from insulin-inducible gene protein (Insig), an endoplasmic reticulum-retention protein, leading to SREBP translocation and lipogenic gene expression. Notably, 25-hydroxycholesterol blocks ammonia to access its binding site on SCAP. Mutating aspartate D428 to alanine prevents ammonia binding to SCAP, abolishes SREBP-1 activation and suppresses tumour growth. Our study characterizes the unknown role, opposite to sterols, of ammonia as a key activator that stimulates SCAP-Insig dissociation and SREBP-1 activation to promote tumour growth and demonstrates that SCAP is a critical sensor of glutamine, glucose and sterol levels to precisely control lipid synthesis.

Indexed as

LipogenesisNeoplasmsAmmoniaGlucoseGlutamineHumansInsulinSterol Regulatory Element Binding Protein 1SterolsAmmoniaGlucoseGlutamineInsulinSterol Regulatory Element Binding Protein 1Sterols

Identifiers

PMID35534729
PMCPMC9177652
OpenAlexW4229453927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.